Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. scores highest on Torque (58) and lowest on Nitro (19). Its PosiPenta is 40.49 out of 100, around the middle of similar companies.
On the Penta Grid this week, Lisata Therapeutics, Inc. is Grid #525 of 836 in the Healthcare sector in United States, and Grid #2,835 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Lisata Therapeutics, Inc. | 40.49 | 35 | 40 | 19 | 58 | 50 |
| BioVie Inc. | 39.80 | 39 | 47 | 34 | 43 | 35 |
| Passage Bio, Inc. | 22.70 | 24 | 17 | 18 | 16 | 38 |
| Caring Brands, Inc. | 41.34 | 0 | 54 | 68 | 38 | 47 |
| Intensity Therapeutics, Inc. | 31.25 | 37 | 37 | 11 | 45 | 26 |
| Citius Pharmaceuticals, Inc. | 35.76 | 49 | 35 | 16 | 43 | 36 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.63 |
| P/B ratio | 1.35 |
EEarnings
| Trailing EPS | ₹-155.33 |
| Forward EPS | ₹-109.87 |
NNitro
| Price | 97.56 |
| 52-week high | 480.20 |
| 52-week low | 92.82 |
| Fall from 52-week high | 79.7% |
TTorque
| Return on equity (ROE) | -101.66% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.94 |
| Market cap | ₹105 Cr |
| Insider holding | 22.26% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Lisata Therapeutics, Inc.'s PosiPenta score?
Lisata Therapeutics, Inc.'s PosiPenta is 40.49 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Lisata Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Lisata Therapeutics, Inc. is Grid #525 of 836 in the Healthcare sector in United States, and Grid #2,835 of 3,999 in United States.
Which PosiPenta pillar is strongest for Lisata Therapeutics, Inc.?
Torque (durability), with a score of 58 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Lisata Therapeutics, Inc.?
Nitro (momentum), with a score of 19 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.